Home Business NUE Life Health raises $3.3M for its psychedelics-meets-tech mental wellness platform – TechCrunch

NUE Life Health raises $3.3M for its psychedelics-meets-tech mental wellness platform – TechCrunch

0
NUE Life Health raises $3.3M for its psychedelics-meets-tech mental wellness platform – TechCrunch

[ad_1]

NUE Life Health, a telemedicine startup within the U.S., is creating what it describes as a “next-generation mental wellness solution” using therapies corresponding to psychedelic-assisted therapies, mixed with a graph database-driven app.

The Miami-based startup has raised a $3.Three million seed spherical from buyers together with Jack Abraham (Atomic Ventures, Hims), Shervin Pishevar (previously of Sherpa Ventures, UBER), Martin Varsavsky (Prelude Fertility, Overture), Jon Oringer (Shutterstock, Pareto Holdings), James Bailey (a capstone supporter of the Multidisciplinary Assoc. for Psychedelic Studies) and Christina Getty. All the above are a part of the current diaspora from Silicon Valley to Miami.

NUE Life Health is at the moment working in California, Texas and Florida, with plans for growth throughout the United States. The platform will supply at-home ketamine remedy, thought of the fastest-acting anti-depressant out there, mixed with music therapies and a data-led strategy.

NUE Life says analysis from Johns Hopkins in Baltimore and Imperial College in London on MDMA and psilocybin assisted psychotherapy seems to point that these are “safe alternatives” in treating mental sickness.

Juan Pablo Cappello, NUE Life’s CEO stated: “We view ketamine therapy and psychedelic therapy simply as catalysts for change. While helping patients reset is important, we at NUE Life are committed to helping our members find community and connection through our digital platform well after the effects of any psychedelic therapies have faded.”

NUE Life’s digital platform will leverage “Knowledge Graphs and AI to deliver personalized evidence-based therapies that approach patient care in a holistic manner,” stated Demian Bellumio, co-founder and CTO of NUE Life Health. Its enterprise HIPPA-compliant well being platform plans to launch within the late summer season of 2021.

Christina Getty, a co-founder and investor in NUE Life Health, stated: “With one of five women in the United States relying on an antidepressant to get through the day, and with our losing 22 veterans a day to suicide, we felt compelled to launch a different kind of mental wellness company.”

NUE Life comes as gamers in psychedelic drugs corresponding to MindMed and ATAI are going public.

Bellumio stated the platform creates an in depth “knowledge graph” of the affected person. This permits it to grasp the whole lot about them to be able to diagnose and deal with their mental well being situation, utilizing an strategy referred to as built-in psychiatry. AI algorithms are then deployed to personalize suggestions, from which therapies to make use of, which dietary supplements to take and which music to take heed to throughout remedy. A proprietary music streaming service shall be a part of the providing.

Bellumio previously labored on graph databases whereas at Accenture (the place he ran the Knowledge Graph Center of Excellence for two years) and at NEORIS. The strategy can be employed by United Healthcare, person its “Connected Healthcare” platform.

[ad_2]

Source link